169 related articles for article (PubMed ID: 16990935)
1. The design and synthesis of inhibitors of pantothenate synthetase.
Tuck KL; Saldanha SA; Birch LM; Smith AG; Abell C
Org Biomol Chem; 2006 Oct; 4(19):3598-610. PubMed ID: 16990935
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action.
Wang S; Eisenberg D
Biochemistry; 2006 Feb; 45(6):1554-61. PubMed ID: 16460002
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystallographic and NMR studies of pantothenate synthetase provide insights into the mechanism of homotropic inhibition by pantoate.
Chakrabarti KS; Thakur KG; Gopal B; Sarma SP
FEBS J; 2010 Feb; 277(3):697-712. PubMed ID: 20059543
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
White EL; Southworth K; Ross L; Cooley S; Gill RB; Sosa MI; Manouvakhova A; Rasmussen L; Goulding C; Eisenberg D; Fletcher TM
J Biomol Screen; 2007 Feb; 12(1):100-5. PubMed ID: 17175524
[TBL] [Abstract][Full Text] [Related]
5. Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate.
Zheng R; Dam TK; Brewer CF; Blanchard JS
Biochemistry; 2004 Jun; 43(22):7171-8. PubMed ID: 15170354
[TBL] [Abstract][Full Text] [Related]
6. Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase.
Zheng R; Blanchard JS
Biochemistry; 2001 Oct; 40(43):12904-12. PubMed ID: 11669627
[TBL] [Abstract][Full Text] [Related]
7. Positional isotope exchange analysis of the pantothenate synthetase reaction.
Williams L; Zheng R; Blanchard JS; Raushel FM
Biochemistry; 2003 May; 42(17):5108-13. PubMed ID: 12718554
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate.
Wang S; Eisenberg D
Protein Sci; 2003 May; 12(5):1097-108. PubMed ID: 12717031
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.
Ciulli A; Scott DE; Ando M; Reyes F; Saldanha SA; Tuck KL; Chirgadze DY; Blundell TL; Abell C
Chembiochem; 2008 Nov; 9(16):2606-11. PubMed ID: 18821554
[No Abstract] [Full Text] [Related]
10. A comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies.
Tan YS; Fuentes G; Verma C
Proteins; 2011 Jun; 79(6):1715-27. PubMed ID: 21425349
[TBL] [Abstract][Full Text] [Related]
11. A novel isoform of pantothenate synthetase in the Archaea.
Ronconi S; Jonczyk R; Genschel U
FEBS J; 2008 Jun; 275(11):2754-64. PubMed ID: 18422645
[TBL] [Abstract][Full Text] [Related]
12. Substrate-induced closing of the active site revealed by the crystal structure of pantothenate synthetase from Staphylococcus aureus.
Satoh A; Konishi S; Tamura H; Stickland HG; Whitney HM; Smith AG; Matsumura H; Inoue T
Biochemistry; 2010 Aug; 49(30):6400-10. PubMed ID: 20568730
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of Escherichia coli phosphoribosylaminoimidazolesuccinocarboxamide synthetase.
Nelson SW; Binkowski DJ; Honzatko RB; Fromm HJ
Biochemistry; 2005 Jan; 44(2):766-74. PubMed ID: 15641804
[TBL] [Abstract][Full Text] [Related]
14. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.
Strancar K; Blanot D; Gobec S
Bioorg Med Chem Lett; 2006 Jan; 16(2):343-8. PubMed ID: 16271472
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of E. coli pantothenate synthetase confirms it as a member of the cytidylyltransferase superfamily.
von Delft F; Lewendon A; Dhanaraj V; Blundell TL; Abell C; Smith AG
Structure; 2001 May; 9(5):439-50. PubMed ID: 11377204
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
Tsukamoto T; Haile WH; McGuire JJ; Coward JK
Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
[TBL] [Abstract][Full Text] [Related]
19. D-Alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin.
Wu D; Kong Y; Han C; Chen J; Hu L; Jiang H; Shen X
Int J Antimicrob Agents; 2008 Nov; 32(5):421-6. PubMed ID: 18774266
[TBL] [Abstract][Full Text] [Related]
20. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
